InflaRx (IFRX) Share-based Compensation (2019 - 2026)

InflaRx's (IFRX) quarterly Share-based Compensation came in at $1.1 million in Q1 2026, down 57.76% year-on-year from $2.6 million in Q1 2025, and up 263.7% quarter-over-quarter from $302937.7 in Q4 2025.

InflaRx (IFRX) Share-based Compensation (2019 - 2026) Analysis & Trends

InflaRx has disclosed Share-based Compensation across 8 years of filings, most recently posting $1.1 million for Q1 2026.

  • Share-based Compensation for Q1 2026 came in at $1.1 million, down 57.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.4 million (down 32.8% YoY), and the FY2025 annual result was $5.2 million, up 19.08% from the prior year.
  • Share-based Compensation came in at $1.1 million for Q1 2026 at InflaRx, up from $302937.7 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $2.8 million in Q1 2022 to a low of $302937.7 in Q4 2025.
  • The 5-year median for Share-based Compensation is $1.1 million (2026), against an average of $1.2 million.
  • Across the five-year window, Share-based Compensation jumped 95.98% in 2022 and plunged 57.76% in 2026, its largest moves.
  • InflaRx's Share-based Compensation stood at $472716.3 in 2022, then climbed by 3.11% to $487398.6 in 2023, then retreated by 25.48% to $363215.6 in 2024, then retreated by 16.6% to $302937.7 in 2025, then jumped by 263.7% to $1.1 million in 2026.
  • The last three Share-based Compensation figures came in at $1.1 million (Q1 2026), $302937.7 (Q4 2025), and $696615.4 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 305,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 166.40 Mn
9 Abivax 94.26 Bn 94.26 Bn - 26.47 Mn
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 1.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.10 Mn
Mar 31, 2026 1.10 Mn
Dec 31, 2025 302,937.67
Dec 31, 2025 302,937.67
Sep 30, 2025 696,615.38
Sep 30, 2025 696,615.38
Jun 30, 2025 1.25 Mn
Jun 30, 2025 1.25 Mn
Mar 31, 2025 2.61 Mn
Mar 31, 2025 2.61 Mn
Dec 31, 2024 363,215.58
Dec 31, 2024 363,215.58
Sep 30, 2024 716,142.35
Sep 30, 2024 716,142.35
Jun 30, 2024 1.31 Mn
Jun 30, 2024 1.31 Mn
Mar 31, 2024 2.02 Mn
Mar 31, 2024 2.02 Mn
Dec 31, 2023 487,398.63
Dec 31, 2023 487,398.63